Correlation Between Novotek AB and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both Novotek AB and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novotek AB and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novotek AB and Enorama Pharma AB, you can compare the effects of market volatilities on Novotek AB and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novotek AB with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novotek AB and Enorama Pharma.
Diversification Opportunities for Novotek AB and Enorama Pharma
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Novotek and Enorama is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Novotek AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Novotek AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novotek AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Novotek AB i.e., Novotek AB and Enorama Pharma go up and down completely randomly.
Pair Corralation between Novotek AB and Enorama Pharma
Assuming the 90 days trading horizon Novotek AB is expected to generate 0.68 times more return on investment than Enorama Pharma. However, Novotek AB is 1.46 times less risky than Enorama Pharma. It trades about 0.28 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about -0.03 per unit of risk. If you would invest 5,600 in Novotek AB on August 25, 2024 and sell it today you would earn a total of 1,100 from holding Novotek AB or generate 19.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Novotek AB vs. Enorama Pharma AB
Performance |
Timeline |
Novotek AB |
Enorama Pharma AB |
Novotek AB and Enorama Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novotek AB and Enorama Pharma
The main advantage of trading using opposite Novotek AB and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novotek AB position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.Novotek AB vs. Softronic AB | Novotek AB vs. Prevas AB | Novotek AB vs. FormPipe Software AB | Novotek AB vs. Dedicare AB |
Enorama Pharma vs. Stille AB | Enorama Pharma vs. Midsona AB | Enorama Pharma vs. C Rad AB | Enorama Pharma vs. Novotek AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Valuation Check real value of public entities based on technical and fundamental data |